Jilin Province Xidian Pharmaceutical Sci-Tech Development Co.,Ltd
Shenzhen Stock ExchangeTotal Valuation
Jilin Province Xidian Pharmaceutical Sci-Tech Development Co.,Ltd carries a market capitalization of 1.99B, placing it among publicly traded companies globally. Its enterprise value stands at 1.93B, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.
| Market Cap | 1.99B |
| Enterprise Value | 1.93B |
Share Statistics
Jilin Province Xidian Pharmaceutical Sci-Tech Development Co.,Ltd currently has 76.49M shares outstanding.
| Shares Outstanding | 76.49M |
| Owned by Insiders (%) | N/A |
| Owned by Institutions (%) | N/A |
Valuation Ratios
Jilin Province Xidian Pharmaceutical Sci-Tech Development Co.,Ltd trades at a trailing price-to-earnings ratio of 52.56. The price-to-sales ratio is 8.38, and the price-to-book ratio stands at 4.53.
| PE Ratio | 52.56 |
| PS Ratio | 8.38 |
| PB Ratio | 4.53 |
| P/TBV Ratio | 2.62 |
| P/FCF Ratio | 21.60 |
| P/OCF Ratio | N/A |
Enterprise Valuation
On an enterprise value basis, Jilin Province Xidian Pharmaceutical Sci-Tech Development Co.,Ltd trades at an EV/EBITDA multiple of 47.14 and an EV/FCF ratio of 19.37. The EV/Sales ratio of 7.53 reflects the premium investors are willing to pay for the company's revenue stream, while the EV/EBIT multiple of 47.14 provides insight into valuation relative to core operating earnings.
| EV / Sales | 7.53 |
| EV / EBITDA | 47.14 |
| EV / EBIT | 47.14 |
| EV / FCF | 19.37 |
Financial Position
Jilin Province Xidian Pharmaceutical Sci-Tech Development Co.,Ltd maintains a current ratio of 5.17, meaning it holds 5.2x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 1.07, indicating moderate leverage, while an interest coverage ratio of 137.35 demonstrates strong ability to service its debt obligations.
| Current Ratio | 5.17 |
| Quick Ratio | 3.68 |
| Debt / Equity | 1.07 |
| Debt / EBITDA | 0.25 |
| Interest Coverage | 137.35 |
Financial Efficiency
Jilin Province Xidian Pharmaceutical Sci-Tech Development Co.,Ltd posts a return on equity of 8.73 and a return on invested capital of 3.80.
| Return on Equity (ROE) | 8.73 |
| Return on Assets (ROA) | 4.03 |
| Return on Invested Capital (ROIC) | 3.80 |
| Return on Capital Employed (ROCE) | 8.68 |
| Revenue Per Employee | N/A |
| Employee Count | N/A |
| Inventory Turnover | 2.44 |
Taxes
Over the trailing twelve months, Jilin Province Xidian Pharmaceutical Sci-Tech Development Co.,Ltd has paid 6.27M in income taxes, reflecting an effective tax rate of 13.77.
| Income Tax | 6.27M |
| Effective Tax Rate | 13.77 |
Stock Price Statistics
Jilin Province Xidian Pharmaceutical Sci-Tech Development Co.,Ltd's stock has declined approximately -14.90826% over the past 52 weeks. The 50-day moving average sits at 28.80, while the 200-day moving average is 30.23.
| Beta (5Y) | N/A |
| 52-Week Price Change | -14.90826% |
| 50-Day Moving Average | 28.80 |
| 200-Day Moving Average | 30.23 |
| Average Volume (20 Days) | N/A |
Income Statement
Over the trailing twelve months, Jilin Province Xidian Pharmaceutical Sci-Tech Development Co.,Ltd generated 255.75M in revenue and converted that into 40.76M in net income, yielding earnings per share of 0.51. EBITDA reached 40.86M, while operating income came in at 40.86M.
| Revenue | 255.75M |
| Gross Profit | 195.32M |
| Operating Income | 40.86M |
| Pretax Income | 45.57M |
| Net Income | 40.76M |
| EBITDA | 40.86M |
| EBIT | 40.86M |
| Earnings Per Share (EPS) | 0.51 |
Balance Sheet
Jilin Province Xidian Pharmaceutical Sci-Tech Development Co.,Ltd holds 260.16M in cash and equivalents against 10.13M in total debt, resulting in a net debt position of -93.13M. Total book value stands at 473.27M, with working capital of 294.70M providing operational flexibility.
| Cash & Cash Equivalents | 260.16M |
| Total Debt | 10.13M |
| Net Debt | -93.13M |
| Equity (Book Value) | 473.27M |
| Book Value Per Share | 6.19 |
| Working Capital | 294.70M |
Cash Flow
After subtracting -99.17M in capital expenditures, free cash flow totaled -99.17M - equivalent to -1.30 per share.
| Operating Cash Flow | N/A |
| Capital Expenditures | -99.17M |
| Free Cash Flow | -99.17M |
| FCF Per Share | -1.30 |
Margins
Jilin Province Xidian Pharmaceutical Sci-Tech Development Co.,Ltd operates with a gross margin of 76.37, reflecting its pricing power and cost economics. The operating margin of 15.98 and net profit margin of 15.94 provide insight into operational efficiency.
| Gross Margin | 76.37 |
| Operating Margin | 15.98 |
| Pretax Margin | 17.82 |
| Profit Margin | 15.94 |
| EBITDA Margin | 15.98 |
Dividends & Yields
The company's payout ratio of 53.25 indicates the proportion of earnings distributed to shareholders.
| Dividend Per Share | 0.26 |
| Dividend Yield | N/A |
| Payout Ratio | 53.25 |
| Shareholder Yield | 1.26 |
| FCF Yield | 4.63 |
Scores
Jilin Province Xidian Pharmaceutical Sci-Tech Development Co.,Ltd posts an Altman Z-Score of 12.99, well above the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.
| Altman Z-Score | 12.99 |